Home - Catalent Pharma

Skip to Main Content Skip to Footer Skip to Search

Contact Us

How can we work together

CELL & GENE THERAPY

CLINICAL SUPPLY

Latest News

Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities

UPTEMPO VIRTUOSO™ AAV PLATFORM PROCESS

A scalable, CGMP-ready process providing early-stage partners with accelerated timelines for production of their clinical material.

Map pin with arrow going around it

Explore our facilities through new 360° Virtual Site Tours and Site Tour Videos to get a window into our integrated services, superior drug delivery technologies and manufacturing solutions across the globe.

This is an icon for the Optidose Design Product

OPTIDOSE® DESIGN SOLUTION

A comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders.

Watch on YouTube

With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs.

SEE ALL LOCATIONS

Map of North America with map pins on facility locations

Map of Europe map with pins on facility locations

Map of South America with map pins on Catalent facilities

Map of Asia-Pacific Region with map pins on facility locations

A person icon with a needle

Catalent is growing & hiring! Join the global drug development and delivery leader that puts “Patient First” at the center of our work every day. Learn more about careers at Catalent.

EXPERT CONTENT

Developing Optimized Formulations with Minimal Drug Substance

Concept to Dosing: Challenges in New Orphan Drugs

Pharmaceutical Outsourcing for Oral Development & Manufacturing

Enabling Successful Scale-Up of a Spray Drying Program

Is My Molecule Suitable for an Orally Disintegrating Tablet?

Emerging Trends and Opportunities in Orally Inhaled Drug Products